Biogen Idec Announces First Startup In Its Innovation Incubator

Biogen Idec (NASDAQ: BIIB) announced the first occupant in its Biogen Idec Innovation Incubator (bi3). Bi3 is a corporate initiative designed to contribute to the company’s drug development pipeline by offering entrepreneurial scientists the opportunity to rapidly convert novel biological insights into life saving and life changing therapies. [click link for full article]

More: continued here

Filed under: Endocrinology on December 30th, 2007